Quality of Life in Patients With Multiple Myeloma

NCT00290095CI-TRIAL-00004531completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The purpose of this study is to determine Clinically important difference and Response shift in quality of life in patients with Multiple Myeloma.

Conditions

Conditions (2)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Multiple Myeloma	Multiple Myeloma	CURATED_EXACT	0.92
Quality of Life	—	UNRESOLVED	—

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* Multiple Myeloma
* Age \> 18 years
* Informed consent

Exclusion Criteria:

* Terminal illness with life expectancy less than 3 months
* Unable to fill in a questionnaire in norwegian

References

Publications (1)

DERIVEDKvam AK, Wisloff F, Fayers PM. Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health Qual Life Outcomes. 2010 Aug 3;8:79. doi: 10.1186/1477-7525-8-79. PMID 20678240

Registry

Dates and enrollment

Start: Jan 1, 2006
Primary completion: Jun 1, 2008
Completion: Jun 1, 2008
First posted: Feb 10, 2006
Last update posted: Mar 8, 2011
Enrollment: 260 (actual)
Lead sponsor: Ullevaal University Hospital OTHER
Keywords: Multiple Myeloma, Quality of Life, Response Shift, Clinically Important Difference

Data updated 22 days agoSource updated Mar 8, 2011source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Norway	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.